4SC AG (XETRA:VSC)
European company
Share Price Chart
- Chart currently unavailable -
Market Info - VSC
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - VSC
- Market Cap€111.250m
- SymbolXETRA:VSC
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINDE000A14KL72
Company Profile
4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. The company's pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development: resminostat and domatinostat.4SC AG focuses on the development of novel small molecule drugs that can target key indications in cancer through epigenetic mechanisms. The company’s product consists of resminostat, 4SC-202, and 4SC-208.
Latest VSC news
Currently there for this company. Visit our news hub for other news .